Rapid Evacuation and Access of Cerebral Hemorrhage Registry: observing minimally invasive surgery outcomes
Official title: A Prospective, Multicenter, Global Registry Evaluating Minimally Invasive Surgery for the Treatment of Acute Spontaneous Supratentorial Intracerebral Hemorrhage.
Run by Emory University · NCT07651631 · Data updated 2026-11-12
This registry collection tests how minimally invasive brain-bleed procedures work in real patients with acute spontaneous intracerebral hemorrhage.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2500 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | August 12, 2026 |
| Main results expected | June 2033 |
| Study ends | June 2033 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07651631 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with acute spontaneous supratentorial ICH, hemorrhage volume ≥ 20 mL, treated with minimally invasive surgery within 7 days of onset.
✕Probably not a fit
Patients with infratentorial hemorrhages, non-MIS management, or comorbidities meeting exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects real-world data on patients with acute spontaneous supratentorial intracerebral hemorrhage who undergo minimally invasive surgical interventions. It aims to quantify outcomes such as functional status and recovery after MIS in the early period following hemorrhage. The study does not assign treatments but records procedures, timing, imaging findings, and outcomes to understand patterns and potential benefits. Eligible patients have hemorrhages of 20 mL or more and receive MIS within seven days, with outcomes analyzed within the registry framework. The investigation is sponsored by Emory University with support from The Marcus Foundation and is conducted at Grady Memorial Hospital in Atlanta, GA.
Why it matters
Potential benefit: If successful, the registry could clarify real-world effectiveness of MIS for ICH and guide future trials and clinical decision-making.
How similar studies have gone: Previous MIS approaches for ICH have shown mixed but growing interest; registry data can help determine real-world effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage * Hemorrhage volume ≥ 20 mLs * Minimally invasive surgical intervention performed within 7 days of hemorrhage Exclusion Criteria: * Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (\<1 year), as diagnosed with radiographic imaging * Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum * Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms * Last known normal is unknown * Historical Modified Rankin Score \> 4 * Known life-expectancy of less than 1 year prior to ICH * DNR or comfort measures only * Known pregnancy in female subjects * Inability or unwillingness of subject or legal guardian/representative to give written informed consent within 7 days of initial hospital arrival * Inability to meet follow up requiremen
Where it's running
-
Grady Memorial Hospital
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Alex Hall, DHSc — Emory University
- Study coordinator: Alex Hall, DHSc
- Email: alex.hall@emory.edu
- Phone: 404-778-1585
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Chinese multicenter group studies spontaneous intracerebral hemorrhage in adults
This study tests how a large group of adults with spontaneous intracerebral hemorrhage (and a healthy control group) progress over time to understand outcomes and determinants of recovery.
-
Single triple-combination blood pressure pill after intracerebral hemorrhage
This trial tests whether a single pill combining amlodipine, valsartan, and hydrochlorothiazide helps adults who recently had an intracerebral hemorrhage control their blood pressure.
-
Vitamin D treatment after intracerebral hemorrhage
This will try giving higher-dose vitamin D to adults within 96 hours of an intracerebral hemorrhage to see if it helps clear the bleed faster and is safe.
-
Prototype CT tools for minimally invasive intracerebral hemorrhage evacuation
This project will test two Siemens prototype CT tools—a perfusion feature and an automatic hemorrhage detector—to see if they help doctors planning and performing minimally invasive brain-bleed (intracerebral hemorrhage) evacuation in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.